Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Present at the 28th Annual Piper Jaffray Healthcare Conference, How Will This News Affect the Share Price?

Medical device company, Tandem Diabetes Care, Inc. (NASDAQ:TNDM), announces that CEO Kim Blickenstaff will speak at the 28th Annual Piper Jaffray Healthcare Conference in NYC.

SAN DIEGO–(BUSINESS WIRE)–

Tandem Diabetes Care®, Inc. (TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that Kim Blickenstaff, president and CEO, will present a company update at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY. The presentation will take place on Wednesday, November 30, 2016 at 3:00PM Eastern Time (12:00PM Pacific Time).

The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim X2™ Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first continuous glucose monitoring-enabled pump with touchscreen simplicity. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, #tslimG4, #tflex, #tconnect, and $TNDM.

Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.

Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

t:slim, t:flex and Tandem Diabetes Care are registered trademarks, and t:slim X2 and t:slim G4 are trademarks of Tandem Diabetes Care, Inc.

Original Source

tandem-diabetes-care-graph

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares have moved -14.55% on the news thus far today and have traded in the range of $2.25 – 2.85 during the current session. In order to take a look at where the stock might be headed longer term, investors often look to research firms that cover the stock. Sell-side research firms currently have a consensus one-year price target of $6.22 on the stock.  This is according to brokerage analysts polled by Thomson Reuters First Call.  The sell-side analysts are projecting earnings per share of $-0.66 for the next fiscal quarter.  For the current year, analysts are predicting earnings of $-2.66 per share according to First Call.

Are Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Ready to Explode?  Sign up to our Newsletter to be the First to Know

Sign up to get our Free Penny Stock Picks Before the Street!

In looking at where the stock is trading on a technical level, the stock is trading -52.33% away from its 50-day moving average of $4.93.  Based on the most recent available data, the equity is -81.17% off of its 52-week high of $12.48 and +46.87% away from its 52-week low which is $1.60.

Today, the stock opened at $2.80 and the last bid at the time of writing stood at $2.35.  During the session thus far, the equity dipped down to $2.25 and touched $2.85 as the high point.  Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has a market cap of $72.01M and has seen an average daily volume of 390,639 over the past three months.

Sign Up to Receive Breaking Alerts on Stocks That Are Primed to Make a Run in the Bar Below.

Sign up to get our Free Penny Stock Picks Before the Street!

Disclaimer: The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice, you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs.  Where quoted, past performance is not indicative of future performance.

Related posts

Leave a Comment